InsiderTrades

Form 4 for BDSX BIODESIX INC

Accepted 2024-05-23 00:00:00 ET · period of report 2024-05-21 · accession 0000905148-24-001610 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMI 2024-05-23 2024-05-23 BDSX Kennedy Lawrence T. Jr Dir, 10% M - OptEx — +4.35M 2.78M New —
DMI 2024-05-23 2024-05-23 BDSX Kennedy Lawrence T. Jr Dir, 10% M - OptEx $0.00 -108.7K 0 -100% $0
DM 2024-05-23 2024-05-21 BDSX Kennedy Lawrence T. Jr Dir, 10% A - Grant $0.00 +83.7K 46.7K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-05-23 M A 1,739,120 — 12,267,873 I By: Lawrence T. Kennedy, Jr. Perpetuity Trust UAD 6/30/16 — — (F1) The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024.
2 Common Common Stock 2024-05-23 M A 2,608,720 — 2,775,386 I By: KFDI-B LLC — — (F1) The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024.
3 Derivative Series A Non-Voting Convertible Preferred Stock 2024-05-23 M D 43,478 $0.00 0 I — · — to — 1,739,120 Common Stock (F1) The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024.
4 Derivative Series A Non-Voting Convertible Preferred Stock 2024-05-23 M D 65,218 $0.00 0 I — · — to — 2,608,720 Common Stock (F1) The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024.
5 Derivative Stock Options (Right to Buy) 2024-05-21 A A 37,050 $0.00 37,050 D By: KFDI-B LLC $1.57 · — to 2034-05-20 37,050 Common Stock (F6) This option will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, this option will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.
6 Derivative Restricted Stock Units 2024-05-21 A A 46,686 $0.00 46,686 D By: Lawrence T. Kennedy, Jr. Perpetuity Trust UAD 6/30/16 — · — to — 46,686 Common Stock (F5) Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer. (F3) Each restricted stock unit (the "RSU") represents a contingent right to receive one share of Common Stock. (F4) These RSUs will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.